Experimental browser for the Atmosphere
How Ozempic and Other GLP-1 Drugs Are Eating Away at Body Positivity
May 8, 2025, 6:53 PM
{ "uri": "at://did:plc:kt5ukeiugdv55f5wqw4kt3nr/app.bsky.feed.post/3loolinz4y22v", "cid": "bafyreidbyle7max77znqjfnjjh5ctv7jseuwpwhghlyoat5jvuuuw3y7iy", "value": { "text": "How Ozempic and Other GLP-1 Drugs Are Eating Away at Body Positivity", "$type": "app.bsky.feed.post", "embed": { "$type": "app.bsky.embed.external", "external": { "uri": "https://buff.ly/AjMyFm9", "thumb": { "$type": "blob", "ref": { "$link": "bafkreie2ny3fv6hnq7mn677fbrr6zafdjnnzpxyoay4d5iowx7ifir6o6u" }, "mimeType": "image/jpeg", "size": 33884 }, "title": "How Ozempic and other GLP-1 drugs are eating away at body positivity", "description": "How GLP-1 drugs like Mounjaro and Ozempic are redefining the debate about size, weight loss and privilege" } }, "createdAt": "2025-05-08T18:53:23.425Z" } }